Several studies also indicated that elevated Gli activity has been observed in various human cancers, including basal cell carcinoma, breast cancer, gastrointestinal cancer, glioma, leukemia, medulloblastoma, melanoma, and prostate cancer [31]. This evidence concerns the gene GLI1 and central nervous system cancer.